Amina Media News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amina media. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amina Media Today - Breaking & Trending Today

Suspended Territories exhibition: Beyond the veil

Superheroes, mythical female figures in the desert: the Suspended Territories exhibition at Germany′s Marta Herford gallery showcases contemporary women's art from the Arab world, Iran and North Africa. By Julia Hitz ....

Nahr El Bared , Lebanon General , Usama Alshaibi , Moufida Fedhila , Donald Trump , Ibn Battuta , Saba Innab , Arwa Arboun , Michael Kroger , Venice Biennale , Marta Herford , Moreshshin Allahyari , Mounira Al Solh , Middle East , Middle Eastern , Nahr El Bared Palestinian , Suspended Territories , Tala Younis , Amina Media , North Africa , Arab Spring , Arab World , Ettadhamen City ,

Suspended Territories exhibition: Beyond the veil

Superheroes, mythical female figures in the desert: the Suspended Territories exhibition at Germany′s Marta Herford gallery showcases contemporary women's art from the Arab world, Iran and North Africa. By Julia Hitz ....

Nahr El Bared , Lebanon General , Usama Alshaibi , Moufida Fedhila , Donald Trump , Ibn Battuta , Saba Innab , Arwa Arboun , Michael Kroger , Venice Biennale , Marta Herford , Moreshshin Allahyari , Mounira Al Solh , Middle East , Middle Eastern , Nahr El Bared Palestinian , Suspended Territories , Tala Younis , Amina Media , North Africa , Arab Spring , Arab World , Ettadhamen City ,

Lilly and MiNA Therapeutics Announce saRNA Research Collaboration


Lilly and MiNA Therapeutics Announce saRNA Research Collaboration
News provided by
Share this article
MiNA Therapeutics Logo
INDIANAPOLIS and LONDON, May 11, 2021 /PRNewswire/  Eli Lilly and Company (NYSE: LLY) and MiNA Therapeutics Limited, a pioneer in RNA activation therapeutics, today announced a global research collaboration to develop novel drug candidates using MiNA s proprietary small activating RNA (saRNA) technology platform.
Under the terms of the agreement, MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly s key therapeutic focus areas. Lilly will be responsible for preclinical and clinical development of candidates and will retain exclusive commercialization rights for any products resulting from the collaboration. MiNA will receive a $25 million upfront payment and is eligible to receive potential development and commercialization milestones up to a total of $245 milli ....

City Of , United Kingdom , Andrewc Adams , Robert Habib , Molly Mccully , Kevin Hern , Sophia Hergenhan , Eli Lilly , Tim Stamper , Exchange Commission , Mina Therapeutics , Generally Accepted Accounting Principles , Private Securities Litigation Reform Act , Lilly Media , Lilly Investors , Victoria Foster Mitchell , Amina Media , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ராபர்ட் ஹபீப் , மாலீ ம்க்குள்ளி , கெவின் ஹெர்ன் , எலி லில்லி , நேரம் ஸ்டாம்பர் , பரிமாற்றம் தரகு , மினா சிகிச்சை ,